When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AIMT - Aimmune +11.6% on positive allergist survey
Aimmune Therapeutics Inc.
Piper Jaffray says a new proprietary allergist survey shows "massive upside" to sales potential and expectations for Aimmune's (NASDAQ:AIMT) peanut allergy drug.
More news on: Aimmune Therapeutics, Inc., Healthcare stocks news, Stocks on the move,